Search results - 65 results
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; Desombere, Isabelle; Ariën, Kevin K; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult ...
Validation of a rapid SARS-CoV-2 antibody test in general practice
Stefan; Van den Bruel, Ann; I Desombere; Van Damme, Pierre; Goossens, Herman; Buret, Laetitia; Duysburgh, Els; Coenen, Samuel Source: BMJ Open, Volume 13, Issue 5 (2023) Health Topics: Health and disease ...
SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study
Publication Type: Peer reviewed scientific article Authors: Milena Callies; Kabouche, Ines; I Desombere; Merckx, Joanna; Roelants, Mathieu; Melissa Vermeulen; Duysburgh, Els Source: BMC Public ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; I Desombere; Ariën, Kevin K.; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Health Topics: Health and ...
SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study
Publication Type: Peer reviewed scientific article Authors: Merckx, Joanna; Milena Callies; Kabouche, Ines; I Desombere; Duysburgh, Els; Roelants, Mathieu Source: Epidemiology and Infection, Volume ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Den Bruel; I Desombere; Van Damme, Pierre; Goossens, Herman; Laëtitia Buret; Els Duysburgh; Coenen, Samuel Source: BMJ Open, Volume 12, Issue 9 (2022) Keywords: Adult Belgium COVID-19 Female Follow-Up ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Publication Type: Peer reviewed scientific article Authors: Frédéric Baron; Lorenzo Canti; Ariën, Kevin K; Delphine Kemlin; I Desombere; Margaux Gerbaux; Pieter Pannus; Yves Beguin; Arnaud Marchant; ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
I Desombere; Sébastien Anguille; Zwi Berneman; Maria Goossens; Goossens, Herman; Surbhi Malhotra-Kumar; Evelina Tacconelli; Timon Vandamme; Peeters, Marc; Peter van Dam; Samir Kumar-Singh Source: Front Immunol, ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Publication Type: Peer reviewed scientific article Authors: Lorenzo Canti; Ariën, Kevin K; I Desombere; Stéphanie Humblet-Baron; Pieter Pannus; Heyndrickx, Leo; Aurélie Henry; Sophie Servais; ...